Description
Tazoter PS 1.125 g IV Injection is a broad-spectrum injectable antibiotic combining Piperacillin and Tazobactam.
-
Piperacillin (1 g): A penicillin-class antibiotic that inhibits bacterial cell wall synthesis, effective against a wide range of Gram-positive and Gram-negative bacteria.
-
Tazobactam (125 mg): A beta-lactamase inhibitor that protects Piperacillin from enzymatic degradation, enhancing activity against resistant bacterial strains.
This formulation is intended for moderate to severe infections, providing rapid intravenous therapy in hospital or clinical settings.
Uses
Tazoter PS 1.125 g IV Injection is prescribed for:
-
Respiratory tract infections (pneumonia, bronchitis)
-
Skin and soft tissue infections
-
Complicated urinary tract infections
-
Intra-abdominal infections (peritonitis)
-
Bloodstream infections (septicemia)
-
Infections caused by beta-lactamase-producing bacteria
Advantages
-
Broad-spectrum IV antibiotic effective against resistant bacteria
-
Beta-lactamase inhibitor ensures higher efficacy
-
Rapid therapeutic action due to intravenous administration
-
Suitable for hospitalized patients and severe infections
Possible Side Effects
Common side effects:
-
Nausea, vomiting, diarrhea
-
Pain or redness at injection site
-
Mild skin rash
Rare but serious side effects:
-
Severe allergic reactions (anaphylaxis)
-
Liver enzyme abnormalities
-
Clostridium difficile-associated diarrhea
-
Blood disorders (neutropenia, thrombocytopenia)
Precautions
-
Administer under medical supervision
-
Inform your doctor if you have penicillin allergy, liver, or kidney disease
-
Monitor for allergic reactions during and after injection
-
Dose adjustment may be required in renal impairment
Leave a Reply